The side-effects of statins have been routinely exaggerated and the benefits under-stated, according to a major review of the evidence published today.
The publication in The Lancet aims to help doctors and the public make informed decisions, researchers said.
The findings were welcomed by senior doctors and heart specialists.
According to the analysis 10,000 people taking statins for five years could prevent major cardiovascular events in 1,000 people with existing disease and in 500 people at high risk through their age, hypertension or diabetes.
In these 10,000 people the treatment would also be linked to up to ten cases of haemorrhagic strokes, up to 100 cases of diabetes and five cases of myopathy, the researchers say. Another 100 patients might also report adverse events such as muscle pain.
The experts say that the level of side-effects has been exaggerated by observational studies.
They say their figures are supported by metanalyses of randomised trials.
Researcher Professor Rory Collins, of Oxford University, UK, said: “Our review shows that the numbers of people who avoid heart attacks and strokes by taking statin therapy are very much larger than the numbers who have side-effects with it. In addition, whereas most of the side-effects can be reversed with no residual effects by stopping the statin, the effects of a heart attack or stroke not being prevented are irreversible and can be devastating.
"Consequently there is a serious cost to public health from making misleading claims about high side-effect rates that inappropriately dissuade people from taking statin therapy despite the proven benefits.”
Professor Jeremy Pearson, from the British Heart Foundation, said: “This comprehensive review reiterates the life-saving benefits of statins, which vastly outweigh the rare side effects associated with the medicine. Evidence, from many objective clinical trials, shows that statins are a safe and effective way of reducing heart attack and stroke risk.
"And there is certainly no debate that people who have had a heart attack or stroke should be taking statins to reduce their risk of another, potentially deadly event."
Dr Maureen Baker, chair of the Royal College of GPs, said: “We hope this research reassures patients who are on statins that in the majority of cases statins are safe and effective drugs – but in most cases where adverse side effects are seen, these are reversible by stopping taking statins.
“As with any new research, it is now important that this study is taken on board as guidelines for healthcare professionals are updated in the best interests of our patients.”
The Lancet 9 September 2016 [abstract]

Leave a Reply